TSC2 c.4336C>G ;(p.P1446A)

Variant ID: 16-2134559-C-G

NM_000548.3(TSC2):c.4336C>G;(p.P1446A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma.

Oncotarget
Spagnolo, Francesco F; Ghiorzo, Paola P; Queirolo, Paola P
Publication Date: 2014-11-15

Variant appearance in text: TSC2: P1446A
PubMed Link: 25344914
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer.

Journal Of Ovarian Research
Gunn, Shelly S; Reveles, Xavier X; Weldon, Korrie K; Barrera, Andres A; Ishaque, Mariam M; Taylor, Dale D; McCaskill, Chris C; Kim, Jaeweon J; Shah, Rashmi R; Mohammed, Mansoor M; Barry, Todd T; Kaiser, Brianne B; Patnaik, Amita A; Tolcher, Anthony A
Publication Date: 2013-01-04

Variant appearance in text: TSC2: P1446A
PubMed Link: 23289505
Variant Present in the following documents:
  • Main text
  • 1757-2215-6-2.pdf
View BVdb publication page